Duration of Contact Precautions for Acute-Care Settings

David B. Banach; Gonzalo Bearman; Marsha Barnden; Jennifer A. Hanrahan; Surbhi Leekha; Daniel J. Morgan; Rekha Murthy; L. Silvia Munoz-Price; Kaede V. Sullivan; Kyle J. Popovich; Timothy L. Wiemken

doi:10.1017/ice.2017.245

Duration of Contact Precautions for Acute-Care Settings

David B. Banach, Gonzalo Bearman, Marsha Barnden, Jennifer A. Hanrahan, Surbhi Leekha, Daniel J. Morgan, Rekha Murthy, L. Silvia Munoz-Price, Kaede V. Sullivan, Kyle J. Popovich, Timothy L. Wiemken

Research output: Contribution to journal › Article › peer-review

57 Scopus citations

Original language	English
Pages (from-to)	127-144
Number of pages	18
Journal	Infection Control and Hospital Epidemiology
Volume	39
Issue number	2
DOIs	https://doi.org/10.1017/ice.2017.245
State	Published - 1 Feb 2018
Externally published	Yes

Access to Document

10.1017/ice.2017.245

Cite this

@article{18c32945845b46e7ac59d60c6a831db0,

title = "Duration of Contact Precautions for Acute-Care Settings",

author = "Banach, {David B.} and Gonzalo Bearman and Marsha Barnden and Hanrahan, {Jennifer A.} and Surbhi Leekha and Morgan, {Daniel J.} and Rekha Murthy and Munoz-Price, {L. Silvia} and Sullivan, {Kaede V.} and Popovich, {Kyle J.} and Wiemken, {Timothy L.}",

note = "Funding Information: D.B., G.B., K.P., M.B., and S.L. report that they have nothing to disclose. D.M. Springer Nature for book and journal editing and research grants from NIH, AHRQ, VA HSRD and CDC. R.M. reports a research grant/contract with Medimmune and Johns Hopkins (lead in multicenter trial: HAIs Among Surgical and ICU Patients: Implications for Interventions and Treatment). L.S.M.P. reports an advisory/consultant role with Xenex/Clorox, and speaker honorarium from Ecolab. K.V.S. reports research grants/contracts with Nanosphere, Inc. (Performance of the Verigene Gram-Negative Blood Culture Test [BC-GN] in Pediatric Patients), Techlab, The Children{\textquoteright}s Hospital of Philadelphia (Evaluation of the Performance of the Shiga Toxin Quik Chek), and Premier EHEC and CHRO-Magar 0157 (The Detection of EHEC Infections in Children). J.H. reports an advisory/consultant role with Gilead. T.W. reports an advisory/consultant role and research grant with Clorox Healthcare (What is the Role of Improved Hydrogen Peroxide in the Operating Room?) and research grants/contracts with the CDC (Enhancing Surveillance Among Refugees), Pfizer (Understanding Why Patients Accept Vaccines: Socio-Behavioral Approach), and University of Louisville research grants > $25,000 with Pfizer and Clorox Healthcare. Funding Information: This study was supported in part by the SHEA Research Network (SRN). We express immense gratitude to Valerie M. Deloney, MBA for her editorial assistance and invaluable organizational expertise in coordinating this project. We also wish to thank Erica S. Shenoy, MD, PhD, for her extensive and thoughtful review of the manuscript.",

year = "2018",

month = feb,

day = "1",

doi = "10.1017/ice.2017.245",

language = "English",

volume = "39",

pages = "127--144",

journal = "Infection Control and Hospital Epidemiology",

issn = "0899-823X",

publisher = "Cambridge University Press",

number = "2",

}

TY - JOUR

T1 - Duration of Contact Precautions for Acute-Care Settings

AU - Banach, David B.

AU - Bearman, Gonzalo

AU - Barnden, Marsha

AU - Hanrahan, Jennifer A.

AU - Leekha, Surbhi

AU - Morgan, Daniel J.

AU - Murthy, Rekha

AU - Munoz-Price, L. Silvia

AU - Sullivan, Kaede V.

AU - Popovich, Kyle J.

AU - Wiemken, Timothy L.

N1 - Funding Information: D.B., G.B., K.P., M.B., and S.L. report that they have nothing to disclose. D.M. Springer Nature for book and journal editing and research grants from NIH, AHRQ, VA HSRD and CDC. R.M. reports a research grant/contract with Medimmune and Johns Hopkins (lead in multicenter trial: HAIs Among Surgical and ICU Patients: Implications for Interventions and Treatment). L.S.M.P. reports an advisory/consultant role with Xenex/Clorox, and speaker honorarium from Ecolab. K.V.S. reports research grants/contracts with Nanosphere, Inc. (Performance of the Verigene Gram-Negative Blood Culture Test [BC-GN] in Pediatric Patients), Techlab, The Children’s Hospital of Philadelphia (Evaluation of the Performance of the Shiga Toxin Quik Chek), and Premier EHEC and CHRO-Magar 0157 (The Detection of EHEC Infections in Children). J.H. reports an advisory/consultant role with Gilead. T.W. reports an advisory/consultant role and research grant with Clorox Healthcare (What is the Role of Improved Hydrogen Peroxide in the Operating Room?) and research grants/contracts with the CDC (Enhancing Surveillance Among Refugees), Pfizer (Understanding Why Patients Accept Vaccines: Socio-Behavioral Approach), and University of Louisville research grants > $25,000 with Pfizer and Clorox Healthcare. Funding Information: This study was supported in part by the SHEA Research Network (SRN). We express immense gratitude to Valerie M. Deloney, MBA for her editorial assistance and invaluable organizational expertise in coordinating this project. We also wish to thank Erica S. Shenoy, MD, PhD, for her extensive and thoughtful review of the manuscript.

PY - 2018/2/1

Y1 - 2018/2/1

UR - http://www.scopus.com/inward/record.url?scp=85044278692&partnerID=8YFLogxK

U2 - 10.1017/ice.2017.245

DO - 10.1017/ice.2017.245

M3 - Article

C2 - 29321078

AN - SCOPUS:85044278692

SN - 0899-823X

VL - 39

SP - 127

EP - 144

JO - Infection Control and Hospital Epidemiology

JF - Infection Control and Hospital Epidemiology

IS - 2

ER -